drugset / Trial / NCT00284856

Montelukast Asthmatic Smoker Study (0476-332)(COMPLETED)

NCT00284856

Phase 3 Completed 1640 enrolled Organon and Co
RandomizedParallel-groupDouble-blindTreatment

Summary

This is a multicenter study to evaluate the efficacy and safety of MK0476 versus placebo in participants with chronic asthma who actively smoke cigarettes.

Timeline

Start
2006-05
Primary completion
2010-04
Completion
2010-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Fluticasone propionate Other / unclassified 250 ug
Subject Montelukast Other / unclassified 10 mg Oral

Indications